Drugs / Elvanse®
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07098585 | May → Jun 2025 | attention deficit-hyperactivity disorder | Humanis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Elvanse | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07098585 ↗ |
| Route | Oral | “single dose oral bioequivalence study” NCT07098585 ↗ |